Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bradley J. Bolzon Phd currently holds 149,531 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bradley J. Bolzon Phd has been a net seller of CRSP stock. They have purchased $27.3M and sold $137.9M worth of shares.
Bradley J. Bolzon Phd's most recent insider trade was on Jul 19, 2021, when they sold 1,324 shares at $127.36 per share.
Bradley J. Bolzon Phd serves as Executive at CRISPR Therapeutics AG (CRSP). They have executed 437 insider transactions totaling $165.1M over their tenure at the company.
Bradley J. Bolzon Phd holds the position of Executive at CRISPR Therapeutics AG, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Bradley J. Bolzon Phd has shown a selling trading pattern, with $27.3M in total purchases and $137.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bradley J. Bolzon Phd was on Jun 28, 2021, when they purchased $3.0M worth of GLUE shares. This transaction involved 157,895 shares at $19.00 per share.
Bradley J. Bolzon Phd currently owns 149,531 shares of CRISPR Therapeutics AG (CRSP), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bradley J. Bolzon Phd's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bradley J. Bolzon Phd has 437 Form 4 filings on record as an insider at CRISPR Therapeutics AG.
Set alerts for Bradley J. Bolzon Phd and 40,000+ other insiders.